Suppr超能文献

肢体非转移性骨肉瘤的局部复发与局部控制:单机构27年经验

Local recurrence and local control of non-metastatic osteosarcoma of the extremities: a 27-year experience in a single institution.

作者信息

Bacci Gaetano, Forni Cristiana, Longhi Alessandra, Ferrari Stefano, Mercuri Mario, Bertoni Franco, Serra Massimo, Briccoli Antonio, Balladelli Alba, Picci Piero

机构信息

Chemotherapy, Department of Musculoskeletal Oncology, Istituto Ortopedico Rizzoli, Bologna, Italy.

出版信息

J Surg Oncol. 2007 Aug 1;96(2):118-23. doi: 10.1002/jso.20628.

Abstract

BACKGROUND

Indications and contraindications for limb salvage versus amputation for local treatment of osteosarcoma of the extremity are still controversial.

PATIENTS AND METHODS

Patients (1,126) with non-metastatic osteosarcoma of the extremity, treated in a single institution between 1972 and 1999 with different protocols of adjuvant and neoadjuvant chemotherapy were evaluated to establish factors that could influence local recurrence (LR) and outcome.

RESULTS

The 5-year event-free survival and overall survival were 55% and 66%. At a follow-up ranging between 5.5 and 32.5 years (mean18.6 years) of the 1,126 evaluated patients, 607 (54%) remained continuously disease-free and 519 relapsed. LR developed in 61 patients (5.4%) after a median time of 2.3 years (0.2-17). For this group of patients the 5-year post-relapse event-free survival and overall survival from the last relapse were, respectively, 11.4% and 16.4%. At the multivariate analyses only surgical margins and histologic response to preoperative treatment resulted to be independent prognostic factors for LR.

CONCLUSION

Considering the risk of LR after surgery with inadequate surgical margins and poor prognosis of LR in osteosarcoma, limb salvage procedures should be performed only when adequate margins surgical margins can be achieved. In case of inadequate margins, an immediate amputation should be considered.

摘要

背景

对于肢体骨肉瘤的局部治疗,保肢与截肢的适应证和禁忌证仍存在争议。

患者与方法

对1972年至1999年间在单一机构接受不同辅助和新辅助化疗方案治疗的1126例肢体非转移性骨肉瘤患者进行评估,以确定可能影响局部复发(LR)和预后的因素。

结果

5年无事件生存率和总生存率分别为55%和66%。在对1126例评估患者进行的5.5至32.5年(平均18.6年)的随访中,607例(54%)持续无病,519例复发。61例患者(5.4%)出现LR,中位时间为2.3年(0.2 - 17年)。对于这组患者,自最后一次复发后的5年复发后无事件生存率和总生存率分别为11.4%和16.4%。多因素分析显示,仅手术切缘和术前治疗的组织学反应是LR的独立预后因素。

结论

考虑到手术切缘不充分时术后LR的风险以及骨肉瘤LR的预后较差,仅当能够获得充分的手术切缘时才应进行保肢手术。如果切缘不充分,应考虑立即截肢。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验